Objective: To summarise evidence on how multidisciplinary team (MDTs) make decisions about identification of imminently dying patients.
Design: Scoping review.
Setting: Any clinical setting providing care for imminently dying patients, excluding studies conducted solely in acute care settings.
Data Sources: The databases AMED, CINAHL, Embase, MEDLINE, PsychINFO and Web of Science were searched from inception to May 2021.Included studies presented original study data written in English and reported on the process or content of MDT discussions about identifying imminently dying adult patients.
Results: 40 studies were included in the review. Studies were primarily conducted using interviews and qualitative analysis of themes.MDT members involved in decision-making were usually doctors and nurses. Some decisions focused on professionals recognising that patients were dying, other decisions focused on initiating specific end-of-life care pathways or clarifying care goals. Most decisions provided evidence for a partial collaborative approach, with information-sharing being more common than joint decision-making. Issues with decision-making included disagreement between staff members and the fact that doctors were often regarded as final or sole decision-makers.
Conclusions: Prognostic decision-making was often not the main focus of included studies. Based on review findings, research explicitly focusing on MDT prognostication by analysing team discussions is needed. The role of allied and other types of healthcare professionals in prognostication needs further investigation as well. A focus on specialist palliative care settings is also necessary.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984043 | PMC |
| http://dx.doi.org/10.1136/bmjopen-2021-057194 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Determining timeframes to death for imminently dying patients: a retrospective cohort study.
BMC Palliat Care
January 2025
Caring Futures Institute, Flinders University, Sturt Rd, Bedford Park, Adelaide, South Australia, 5042, Australia.
Background: Clinicians are frequently asked 'how long' questions at end-of-life by patients and those important to them, yet predicting timeframes to death remains uncertain, even in the last weeks and days of life. Patients and families wish to know so they can ask questions, plan, make decisions, have time to visit and say their goodbyes, and have holistic care needs met. Consequently, this necessitates a more accurate assessment of empirical data to better inform prognostication and reduce uncertainty around time until death.
View Article and Find Full Text PDFA case study of Muslims' perspectives of expanded terminal sedation:addressing the elephant in the room.
BMC Med Ethics
November 2024
School of Nursing, Zarqa University, Zarqa, Jordan.
Background: Recently, the concept of expanded terminal sedation emerged to describe using sedation at the end of life in cases beyond the usual use. Using this sedation could be a stressful ethical encounter for healthcare providers.
Case: In this paper, we describe a case of a Muslim palliative care nurse who cared for a patient with cancer who requested expanded terminal sedation.
Generating Consensus on Good Practices in the Care of Portuguese Internal Medicine Patients Facing Imminent Death: A Delphi Study.
Healthcare (Basel)
October 2024
Internal Medicine, Emergency and Intensive Care Department, Hospital da Luz-Arrábida, 4400-346 Vila Nova de Gaia, Portugal.
Context: Modern medicine aims to ensure a world in which all people experience a good end of life as an integral part of their life journey. A good end-of-life experience means dying with dignity and receiving the best healthcare based on scientific evidence.
Objective: This study aims to reach a consensus about the contents of a comprehensive instrument based on the 10/40 Model of the International Collaborative for the Best Care for the Dying Person for evaluating inpatients facing imminent death in Portuguese internal medicine wards and a proposal for anticipatory medication for symptom control in inpatient and home care settings.
The Time Has Come: The Case for Initiating Pilot Clinical Trials of Pig Kidney Xenotransplantation.
Ann Surg
September 2024
Center for Transplantation Sciences, Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA, USA.
Article Synopsis
- - In vitro studies show that kidney transplants from gene-edited pigs may face more challenges in nonhuman primates (NHPs) than in humans, but pig-to-human transplants have distinct advantages like better communication with the surgical team and improved monitoring methods.
- - Advantages for recipients of xenotransplants include better clinical-grade microbiological management, access to advanced monitoring and imaging techniques, and available therapeutic interventions not easily accessible in NHP models.
- - To expedite safe human clinical trials, it's proposed to start small pilot cases for high-risk patients, particularly those over 60, with specific blood types, or diabetic nephropathy, as many patients on the kidney waitlist die each year due to lack of alternatives.
The Secrets of the Backstage: Directing Death Vigils.
J Palliat Med
December 2024
Division of Palliative Medicine, Department of Medicine, Washington University in St. Louis, St Louis, Missouri, USA.
The majority of hospice patients are over the age of 65, and the majority of hospice deaths occur in private homes. As a hospice patient's disease progresses, death becomes imminent and family and friends gather around to say good-bye. These private vigils are the culmination of the hospice experience and reflect both the strengths and the challenges surrounding hospice care.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!